Pathstone Family Office’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$546K Buy
1,664
+336
+25% +$106K ﹤0.01% 1001
2023
Q2
$400K Buy
1,328
+29
+2% +$8.34K 0.01% 842
2023
Q1
$347K Sell
1,299
-5,279
-80% -$1.52M 0.01% 850
2022
Q4
$1.67M Sell
6,578
-1,109
-14% -$377K 0.01% 561
2022
Q3
$2.54M Buy
7,687
+5,430
+241% +$1.75M 0.02% 360
2022
Q2
$631K Buy
2,257
+342
+18% +$103K 0.01% 490
2022
Q1
$841K Buy
1,915
+299
+19% +$92K 0.02% 376
2021
Q4
$514K Buy
1,616
+56
+4% +$16.7K 0.01% 550
2021
Q3
$424K Buy
1,560
+1
+0.1% +$264 0.01% 572
2021
Q2
$395K Buy
1,559
+90
+6% +$22.6K 0.01% 556
2021
Q1
$343K Buy
+1,469
New +$328K 0.01% 444
2019
Q2
Sell
-18
Closed -$3K 797
2019
Q1
$3K Hold
18
﹤0.01% 695
2018
Q4
$2K Buy
+18
New +$2.36K ﹤0.01% 463

Other funds holding MOH

Pathstone Family Office's MOH Position: Q3 2023 in Review

Pathstone Family Office increased its Molina Healthcare (MOH) stake by 25% in Q3 2023, buying an estimated $106K and bringing the position to 1,664 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Pathstone Family Office first reported a position in MOH in Q4 2018 and has held it in 13 quarters since. The position peaked at $2.54M in Q3 2022. 563 funds tracked by Wall St. Rank hold MOH as of Q3 2023.

  • Pathstone Family Office held 1,664 shares of Molina Healthcare worth $546K as of Q3 2023.
  • Pathstone Family Office bought 336 Molina Healthcare shares in Q3 2023, an estimated $106K.
  • Molina Healthcare made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1001 holding.
  • Pathstone Family Office first reported a position in Molina Healthcare in Q4 2018 and has held it in 13 quarters since.
  • Pathstone Family Office's Molina Healthcare position peaked at $2.54M in Q3 2022.
  • 563 funds tracked by Wall St. Rank held Molina Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.